COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 3 51-3, 2005, Pages

  Ottewell, P D ^a   Varro, A ^a   Dockray, G J ^a   Kirton, C M ^a   Watson, A J M ^a   Wang, T C ^b   Dimaline, R ^a   Pritchard, D M ^a,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Columbia University ^*  (United States)

^c Dept of Medicine   (United Kingdom)

Author keywords

radiation; Azoxymethane; Colon; Mitosis; Progastrin

Indexed keywords

AZOXYMETHANE; GASTRIN 17; PROGASTRIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLON MUCOSA; CONTROLLED STUDY; GAMMA IRRADIATION; GROWTH STIMULATION; HORMONAL REGULATION; KNOCKOUT MOUSE; MITOSIS; MITOSIS INDEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIMETABOLITES; APOPTOSIS; AZOXYMETHANE; BROMODEOXYURIDINE; CARCINOGENS; COLON; DNA DAMAGE; EPITHELIAL CELLS; GAMMA RAYS; GASTRINS; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOGENS; MITOSIS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 13844306704     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00268.2004     Document Type: Article

References (45)

1. Aly A, Shulkes A, and Baldwin GS. Short term infusion of glycine-extended gastrin (17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int J Cancer 94: 307-313, 2001.
2. Azuma T, Magami Y, Habu Y, Kawai K, Taggart RT, and Walsh JH. Carboxyl terminal glycine extended progastrin (gastrin-G) in gastric antral mucosa patients with gastric or duodenal ulcer in gastrinomas. J Gastroenterol Hepatol 5: 525-529, 1990.
3. Baldwin GS and Shulkes A. Gastrin, gastrin receptors and colorectal carcinoma. Gut 42: 581-584, 1998.
4. Baldwin GS and Zhang QX. Measurement of gastrin and transforming growth factor α messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res 52: 2261-2267, 1992.
5. Biagini P, Monges G, Vuaroqueaux V, Parriaux D, Cantaloube JF, and De Micco P. The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines. Life Sci 61: 1009-1018, 1997.
6. Chen D, Zhao CM, Dockray GJ, Varro A, Van Hoek A, Sinclair NF, Wang TC, and Koh TJ. Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice. Gastroenterology 119: 756-765, 2000.
7. Ciccotosto GD, McLeish A, Hardy KJ, and Shulkes A. Expression processing and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 109: 1142-1153, 1995.
8. Clerc P, Dufresne M, Saillan C, Chastre E, Andre T, Escrieut C, Kennedy K, Vaysse N, Gespach C, and Fourmy D. Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon. Int J Cancer 72: 931-936, 1997.
9. Cobb S, Wood T, Ceci J, Varro A, Valasco M, and Singh P. Intestinal expression of mutant and wild-type progastrin significantly increases colon carcinogenesis in response to azoxymethane in transgenic mice. Cancer 100: 1311-1323, 2004.
10. Cobb S, Wood T, Tessarollo L, Valasco M, Given R, Varro A, Tarasova N, and Singh P. Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice. Gastroenterology 123: 516-530, 2002.
11. Dockray GJ, Varro A, and Dimaline R. Gastric endocrine cells: gene expression, processing and targeting of active products. Physiol Rev 76: 767-798, 1996.
12. Dockray GJ, Varro A, Dimaline R, and Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 63: 119-139, 2001.
13. Finley GG, Koski RA, Melhem MF, Pipas JM, and Meisler AL. Expression of gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res 53: 2919-2926, 1993.
14. Hollande F, Imdahl A, Mantamadiotis T, Ciccotosto G, Shulkes A, and Baldwin GS. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology 113: 1576-1588, 1997.
15. Kochman ML, DelValle J, Dickinson CJ, and Boland CR. Posttranslational processing of gastrin in neoplasmic human colonic tissues. Biochem Biophys Res Commun 189: 1165-1169, 1992.
16. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, and Wang TC. Gastrin is a downstream target of the β-catenin/TCF-4 growth signalling pathway in a model of intestinal polyposis. J Clin Invest 106: 533-539, 2000.
17. Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, Dockray GJ, and Wang T. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 113: 1015-1025, 1997.
18. Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, Dockray GJ, and Wang T. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 103: 1119-1126, 1999.
19. Lay JM, Jenkins C, Friis-Hansen L, and Samuelson LC. Structure and developmental expression of the mouse CCK-B receptor gene. Biochem Biophys Res Commun 272: 837-42, 2000.
20. Marshman E, Ottewell PD, Potten CS, and Watson AJM. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol 195: 285-292, 2001.
21. Merritt AJ, Jones LS, and Potten CS. Apoptosis in murine intestinal crypts. In: Techniques in Apoptosis, edited by Cotter TG and Martin SJ. London, UK: Portland, 1996, p. 269-300.
22. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, and Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand J Gastroenterol 31: 383-390, 1996.
23. Nakata H, Wang SL, Chung DC, Westwick JK, and Tillotson LG. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology 115: 1144-1153, 1998.
24. Nemeth J, Taylor B, Pauwels S, Varro A, and Dockray GJ. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 34: 90-95, 1993.
25. Ottewell PD, Watson AJM, Wang TC, Varro A, Dockray GJ, and Pritchard DM. Progastrin stimulates murine colonic epithelial mitosis after DNA damage. Gastroenterology 124: 1348-1357, 2003.
26. Pauwels S, Desmond H, Dimaline R, and Dockray G. Identification of progastrin in gastrinomas, antrum, and duodenum by a novel radioimmunoassay. J Clin Invest 77: 376-81, 1986.
27. Potten CS and Grant HK. The relationship between ionizing radiation induced apoptosis and stem cells in the small and large intestine. Br J Cancer 78: 993-1003, 1998.
28. Pritchard DM, Potten CS, Korsmeyer SJ, Roberts S, and Hickman JA. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice; investigations of the mechanistic determinants of epithelial apoptosis in vivo. Oncogene 18: 7287-7293, 1999.
29. Rehfeld JF. Localisation of gastrins to neuro- and adenohypophysis. Nature 271: 771-773, 1978.
30. Siddeshwar RK, Gray JC, and Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine-extended gastrin are elevated in patients with colorectal carcinoma. Gut 48: 47-52, 2000.
31. Singh P, Valasco M, Given R, Varro A, and Wang TC. Progastrin expression predisposes mice to development of colon carcinoma and adenomas in response to AOM. Gastroenterology 119: 162-171, 2000.
32. Singh P, Valasco M, Given R, Wargovich M, Varro A, and Wang TC. Mice overexpressing progastrin are predisposed for developing aberrant crypt foci in response to AOM. Am J Physiol Gastrointest Liver Physiol 278: G390-G399, 2000.
33. Singh P, Xu Z, Dai B, Rajaraman S, and Dhruva B. Incomplete processing of progastrin expressed by colon cancer cells: role of non-carboxyamidated gastrin in proliferation. Am J Physiol Gastrointest Liver Physiol 266: G459-G468, 1994.
34. Smith AM and Watson SA. Gastrin and colorectal cancer. Aliment Pharmacol Ther 14: 1231-1247, 2000.
35. Stepan VM, Sawada M, Todisco A, and Dickinson CJ. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells. Mol Med 5: 147-159, 1999.
36. Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, and Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 104: 1099-1107, 1993.
37. Varro A, Dockray GJ, Bate GW, Vaillant C, Higham A, Armitage E, and Thompson DG. Gastrin biosynthesis in the antrum of patients with pernicious anemia. Gastroenterology 112: 733-741, 1997.
38. Varro A, Henry J, Vaillant C, and Dockray GJ. Discrimination between temperature- and brefeldin A-sensitive steps in the sulfation, phosphorylation, and cleavage of progastrin and its derivatives. J Biol Chem 269: 20764-70, 1994.
39. Varro A, Voronina S, and Dockray GJ. Pathways of processing of the gastrin precursor in rat antral mucosa. J Clin Invest 95: 1642-1649, 1995.
40. Wang TC, Koh TJ, Varro A, Cahill RC, Dangler CA, and Fox JG. Processing and proliferative effects of human progastrin in transgenic mice. J Clin invest 98: 1918-1929, 1996.
41. Watson AJM and Pritchard DM. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice. Am J Physiol Gastrointest Liver Physiol 278: G1-G5, 2000.
42. Watson SA, Clarke PA, Smith AM, Varro A, Michaeli D, Grimes S, Caplin M, and Hardcastle JD. Expression of CCKB/gastrin receptor isoforms in gastro-intestinal tumour cells. Int J Cancer 77: 572-577, 1998.
43. Min-/+ mouse model of familial adenomatous polyposis. Cancer Res 61: 625-631, 2001.
44. Wu H, Owlia A, and Singh P. Precursor peptide progastrin(1-80) reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATP. Am J Physiol Gastrointest Liver Physiol 285: G1097-G1110, 2003.
45. Wu H, Rao GN, Dai B, and Singh P. Autocrine gastrins in colon cancer cells upregulate cytochrome c oxidase Vb and down-regulate efflux of cytochome c and activation of caspase-3. J Biol Chem 275: 32491-32498, 2000.